ReviewNano-micro letters2026
Next-Generation Joint-on-a-Chip: Toward Precision Mechanical Control in Multi-Tissue Systems.
Review in Nano-micro letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Chondrogenic niche hydrogel microspheres facilitate cartilage regeneration in osteoarthritis.Bioactive materials · 2026Article
- Physicochemically-guided immunomodulatory biomaterials for regulating immune responses in rheumatoid arthritis.Materials today. Bio · 2026Article
- Recent advances in immunocompetent human skin-on-chip models: Construction strategies and biomedical applications.Bioactive materials · 2026Review
- Multi-Tissue Crosstalk Regulating Meniscus Healing Under Inflammation and Physiological Loading.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Strategies for the Selection and Application of Biological Scaffolds in Organ-on-a-Chip Systems.Chembiochem : a European journal of chemical biology · 2026Review
- Peripheral nerve sheath tumors-on-a-chip: Next-generation platforms for mechanistic and therapeutic studies.Materials today. Advances · 2026Article
- Emerging biomodels to understand the pathophysiology of sepsis and evaluate new therapeutic strategies targeting extracellular histones.Materials today. Bio · 2026Review
- Organ-on-chip (OoC) and nano-biomaterials: next generation of precision oral and dental healthcare research.Journal of nanobiotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoarthritis is among the leading causes of disability worldwide, and no pharmacological therapies currently exist to reverse its progression. This lack of therapies is primarily attributed to the inadequacies of conventional in vitro models of joint physiology and pathology, which significantly hinder advancements in disease mechanism research and drug development. As an emerging in vitro joint model, joint-on-a-chip (JoC) technology allows low-cost, efficient simulation of physiological and pathological joint activities, making it a focal point of current research. Cartilage, subchondral bone, and synovium are among the key tissues required for constructing in vitro joint models, with cartilage playing a central load-bearing role in joint movement. This article provides a detailed overview of the structure and function of these tissues, with an emphasis on the load-bearing mechanisms of cartilage, and identifies the microenvironmental characteristics that JoC should aim to replicate. Subsequently, we review the current types of JoC and highlight their core challenge: the seamless integration of multi-tissue co-culture with specific mechanical stimulation. To address this issue, we propose potential solutions and present a conceptual design for a JoC prototype. Finally, we discuss the challenges and issues related to the outlook for JoC. Our ultimate goal is to develop a JoC capable of replicating the key microenvironments of joints, serving as a high-performance in vitro joint model to advance the study of disease mechanisms and facilitate drug development.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.